Stock DVYSR DEVYSER DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Market Closed - Nasdaq Stockholm
Other stock markets
 11:24:44 2024-05-02 EDT 		5-day change 1st Jan Change
99.4 SEK +0.61% Intraday chart for Devyser Diagnostics AB -4.42% +26.46%
04-25 Devyser Receives IVDR Approval for Post-Transplant Monitoring Software CI
03-11 Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Devyser Receives IVDR Approval for Post-Transplant Monitoring Software
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test
Devyser Diagnostics AB Announces Study Publication Demonstrating dd-cfDNA Detection in Dual Donor Kidney Transplant Patient
Devyser Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
Devyser Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Devyser Diagnostics AB Announces Michael Uhlin, CSO Joins Management Team as of February 1, 2024
Devyser's US Lab Inks SEK25 Million Deal with UK Diagnostics Company Cyted
Devyser Genomic Laboratories Signs First Commercial Agreement with Cyted
Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits
Devyser Diagnostics AB Wins Tender for Cystic Fibrosis in Italy
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests
Sweden’s Devyser Wins $6 Million Tender for Cystic Fibrosis Diagnostic Tool in Italy
Devyser Wins Approximately SEK 2 Million Tender for Cystic Fibrosis
Devyser Diagnostics Bags Non-invasive Fetal RHD Test Tender in Wales
Devyser wins tender for non-invasive fetal RHD testing in Wales
Devyser Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Devyser and Thermo Fisher Scientific Collaborate to Promote Laboratory Services to Advance Pharmaceutical Research
Thermo Fisher Scientific to Sell Devyser Diagnostics' Transplantation Products in Brazil
Devyser and Thermo Fisher Scientific Expand the Collaboration for Post-Transplant Ngs Products by Adding Brazil
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DVYSR Stock
  4. News Devyser Diagnostics AB
  5. Other languages